Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

JHS Svendgaard Laboratories Ltd. Board/Management Information 2025

Aug 21, 2025

61621_rns_2025-08-21_157fd0e2-e3e5-4e41-a737-41c9d862d92a.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [107 x 79] intentionally omitted <==

CIN : L74110HP2004PLC027558

To,

Date: 21-08-2025

The Listing Department The Listing Department Bombay Stock Exchange Limited National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, C-1, Block-G Phiroze Jeejeebhoy Towers, Bandra Kurla Complex Dalal Street Mumbai – 400001 Mumbai – 400051 Scrip Code: 532771 Trading Symbol: JHS

Sub: Outcome of Board Meeting held on August 21, 2025.

Dear Sir,

In accordance with the provisions of the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the “Listing Regulations”), we wish to inform you that a meeting of Board of Directors of the Company was held today i.e. August 21, 2025 commenced at 05:00 P.M. and concluded at 05:10 P.M. to considered and approved JHS Svendgaard Laboratories Employee Stock Option Scheme – 2025 (“Scheme”) .

The disclosure pursuant to SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, is enclosed herewith as ANNEXURE-A .

Please take the aforesaid on your records and acknowledge the receipt.

Thanking You,

For and on the behalf of, JHS Svendgaard Laboratories Limited

Digitally signed by KOMAL KOMAL JHA JHA Date: 2025.08.21 17:27:46 +05'30'

Komal Jha

Company Secretary and Compliance Officer

==> picture [486 x 48] intentionally omitted <==

==> picture [107 x 79] intentionally omitted <==

CIN : L74110HP2004PLC027558

ANNEXURE A

Details under Regulation 30 of the SEBI Listing Regulations read along with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Sl.
No.
Particulars Details
**1. ** Name of the Scheme JHS Svendgaard Laboratories Employee Stock Option
Scheme – 2025(“Scheme”)
**2. ** Brief details of options granted The ESOP pool of 40,00,000 (Forty Lakhs) Options
convertible into 40,00,000 (Forty Lakhs) Equity Shares
of face value of Rs. 10/- each.
The Scheme shall be implemented through direct route
to extend the benefits to the Eligible Employees by the
way of fresh allotment from the Company.
However, no grant has been made under the Scheme,
as on date.
**3. ** Whether the Scheme is in terms
of
SEBI
(SBEB
&
SE)
Regulations, 2021 (if applicable)
Yes
**4. ** Total number of shares covered
by these options
40,00,000 (Forty Lakhs) Equity Shares of face value
Rs. 10/- each (Each Option is convertible into one
Equity Share of the Company).
**5. ** Pricing Formula Under this Scheme, the Exercise Price will be decided
by the Committee at the time of Grant and shall be
linked with the Market Price as defined in the Scheme.
The Committee has the power to provide suitable
discount on such price as arrived above. However, in
any case the Exercise Priceshall not go below the face
value of the Share of the Company.
**6. ** Options Vested Not Applicable, as this outcome is pertaining to date of
approval of Board of Directors.
**7. ** Time within which option may
be exercised
All Options upon vesting shall be exercisable within
maximum of 5 (five) year from the date of respective
vesting.
**8. ** Options exercised

==> picture [486 x 48] intentionally omitted <==

==> picture [107 x 79] intentionally omitted <==

CIN : L74110HP2004PLC027558

CIN : L74110HP2004PLC02755
**9. ** Money realized by exercise of
Options
Not Applicable, as this outcome is pertaining to date of
approval of Board of Directors.
**10. ** The total number of Shares
arising as a result of exercise of
Option
**11. ** Options lapsed
**12. ** Variation in terms of Options
**13. ** Brief details of significant terms The Scheme is administered by the Nomination and
Remuneration Committee.
The Scheme shall be implemented through direct route
to extend the benefits to the Eligible Employees by the
way of fresh allotment from the Company.
The grant of Options is based upon the eligibility
criteria as mentioned in the Scheme.
The Vesting Period shall commence from a period of 1
(One) year from the Grant Date and shall extend upto
a maximum period of 5 (Five) years from the Grant
Date, at the discretion of and in the manner prescribed
by the Committee and set out in the Grant Letter.
The granted Options once vested shall entitle the
Option holder to acquire equal number of Equity
Shares, upon payment of exercise price, applicable
taxes and other charges, if any, in accordance with
terms and conditions of the Scheme.
All Vested Options shall be respectively exercised in
one or more tranches within maximum period of 5
(Five) years from the date of respective vesting.
**14. ** Subsequent
changes
or
cancellation or exercise of such
Options
Not Applicable, as this outcome is pertaining to date of
approval of Board of Directors.
**15. ** Diluted
earnings
per
share
pursuant to the issue of equity
shares on exercise of Options.

==> picture [486 x 48] intentionally omitted <==